Suzhou Industrial Park Heshun Electric
300141
Guangdong Xiongsu Technology Group
300599
Sichuan Chuanhuan Technology
300547
Shanghai Wisdom Information Technology
301315
KANGNONG SEED
837403
CN Stock MarketDetailed Quotes
300683 Wuhan Hiteck Biological Pharma
- 24.41
- +0.23+0.95%
Market Closed Dec 27 15:00 CST
3.20BMarket Cap-23.81P/E (TTM)
24.60High23.93Low6.39KlotVolume24.19Open24.18Pre Close15.59MTurnover0.52%Turnover RatioLossP/E (Static)130.89MShares36.0052wk High1.31P/B2.98BFloat Cap18.8052wk Low29.02Limit Up122.06MShs Float84.84Historical High19.34Limit Down2.77%Amplitude18.80Historical Low--Dividend TTM24.40Avg Price2.80KlotAsk--Div YieldTTM100Lot Size3.47KlotBid
Wuhan Hiteck Biological Pharma Key Stats
All
YOY
| (Q9)Sep 30, 2024 | (Q6)Jun 30, 2024 | (Q3)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q9)Sep 30, 2023 | (Q6)Jun 30, 2023 | (Q3)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q9)Sep 30, 2022 | (Q6)Jun 30, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | ||||||||||
| Goods sale service render cash | -4.02%420.7M | -9.01%277.08M | -10.54%133.87M | -8.50%622.51M | -11.13%438.33M | -2.01%304.51M | -6.71%149.64M | 24.43%680.36M | 35.51%493.22M | 25.51%310.76M |
| Refunds of taxes and levies | -78.45%4.69M | -92.88%1.46M | -85.51%5.2K | 42.36%33.16M | 40.79%21.77M | 63.98%20.44M | 99.57%35.87K | 190.11%23.29M | 3,512.18%15.46M | 2,811.24%12.46M |
| Cash received relating to other operating activities | 237.01%96.89M | 450.54%93.57M | 492.65%55.94M | -17.05%26.27M | 6.49%28.75M | -7.91%17M | 32.76%9.44M | 14.51%31.67M | 9.67%27M | 15.60%18.46M |
| Cash inflows from operating activities | 6.84%522.28M | 8.82%372.1M | 19.29%189.81M | -7.26%681.93M | -8.74%488.85M | 0.08%341.94M | -5.02%159.11M | 26.24%735.32M | 37.70%535.68M | 29.43%341.68M |
| Goods services cash paid | -18.56%151.61M | -27.44%104.39M | -19.35%57.11M | -10.75%243.41M | -22.04%186.17M | -19.28%143.86M | -30.66%70.82M | 56.96%272.73M | 109.09%238.82M | 153.31%178.22M |
| Staff behalf paid | 14.57%214.7M | 19.19%151.79M | 25.26%88.8M | 20.82%252.54M | 26.60%187.39M | 27.21%127.36M | 25.53%70.89M | 20.84%209.03M | 17.01%148.02M | 6.67%100.11M |
| All taxes paid | -5.09%20.35M | -28.82%12.63M | -25.66%5.27M | -26.43%24.01M | -27.41%21.44M | 3.61%17.75M | -23.01%7.09M | 15.45%32.63M | 41.71%29.54M | -6.06%17.13M |
| Cash paid relating to other operating activities | -21.62%107.87M | -13.16%73.06M | -2.83%29.48M | -6.70%156.65M | 21.03%137.62M | 12.64%84.13M | -24.40%30.34M | -14.07%167.9M | -10.51%113.71M | -17.21%74.69M |
| Cash outflows from operating activities | -7.15%494.54M | -8.37%341.87M | 0.85%180.67M | -0.83%676.62M | 0.48%532.63M | 0.80%373.1M | -13.85%179.14M | 19.62%682.28M | 36.40%530.09M | 35.75%370.15M |
| Net cash flows from operating activities | 163.36%27.74M | 197.05%30.24M | 145.66%9.14M | -89.98%5.31M | -883.59%-43.78M | -9.44%-31.16M | 50.46%-20.03M | 338.72%53.03M | 1,321.14%5.59M | -228.35%-28.47M |
| Investing cash flow | ||||||||||
| Cash received from disposal of investments | -4.16%1.04B | -35.15%589.18M | -38.34%172.94M | -19.95%1.46B | 7.68%1.08B | 4.19%908.57M | 146.93%280.5M | 23.63%1.83B | 32.75%1.01B | 74.04%872.02M |
| Cash received from returns on investments | 43.35%13.95M | 3.21%6.6M | -78.38%470.9K | 27.78%19.43M | -27.80%9.73M | -42.26%6.39M | 13.64%2.18M | 0.34%15.21M | 59.57%13.48M | 53.44%11.07M |
| Net cash received from disposal of fix assets、 intangible assets 、other long-term asset | -99.27%15K | ---- | ---- | 9,147.11%2.07M | 13,419.83%2.07M | 1,630.53%261.31K | ---- | 16.72%22.38K | 1,810.00%15.28K | 2,920.00%15.1K |
| Net cash received from disposal of subsidiaries and other business units | ---- | ---- | ---- | ---- | ---- | ---- | ---- | -29.93%3M | --2.55M | --2.55M |
| Cash inflows from investing activities | -3.92%1.05B | -34.90%595.78M | -38.65%173.42M | -19.57%1.48B | 7.14%1.09B | 3.34%915.23M | 144.72%282.68M | 23.24%1.85B | 33.38%1.02B | 74.25%885.66M |
| Cash paid to acquire fixed assets intangible assets and other long-term assets | -69.83%29.46M | -57.54%23.94M | -67.09%16.87M | -3.75%167.44M | -28.07%97.65M | -40.06%56.4M | -9.13%51.26M | -29.60%173.97M | -27.72%135.76M | -10.68%94.1M |
| Cash paid to acquire investments | -28.81%1.05B | -49.71%719.03M | -64.21%207.82M | 60.97%1.81B | 109.01%1.47B | 241.92%1.43B | 432.12%580.73M | -43.99%1.12B | -22.18%705.45M | -35.93%418.2M |
| Net cash paid to acquire subsidiaries and other business units | ---- | ---- | ---- | ---- | -68.81%7.09M | -77.21%7.09M | ---- | -88.47%22.72M | --22.72M | --31.11M |
| Cash paid relating to other investing activities | ---- | ---- | ---- | -33.33%126K | ---- | ---- | --71.25K | -4.55%189K | ---- | ---- |
| Cash outflows from investing activities | -31.66%1.08B | -50.25%742.97M | -64.45%224.68M | 49.66%1.98B | 82.80%1.58B | 174.82%1.49B | 281.81%632.06M | -46.11%1.32B | -21.06%863.93M | -28.32%543.4M |
| Net cash flows from investing activities | 94.28%-27.74M | 74.54%-147.2M | 85.33%-51.27M | -193.64%-491.93M | -407.94%-484.89M | -268.92%-578.16M | -598.31%-349.38M | 155.13%525.36M | 147.92%157.46M | 236.99%342.26M |
| Financing cash flow | ||||||||||
| Cash received from capital contributions | ---- | ---- | ---- | --290M | --290M | --290M | --290M | ---- | ---- | ---- |
| Cash from borrowing | ---- | ---- | ---- | --10M | --10M | ---- | ---- | ---- | ---- | ---- |
| Cash received relating to other financing activities | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | --1.73M | ---- |
| Cash inflows from financing activities | ---- | ---- | ---- | --300M | 17,239.11%300M | --290M | --290M | ---- | -99.73%1.73M | ---- |
| Borrowing repayment | -67.41%10.95M | -77.47%7.3M | 204.17%3.65M | 668.29%47.25M | 578.79%33.6M | 653.49%32.4M | -67.12%1.2M | 2.50%6.15M | -45.00%4.95M | -46.25%4.3M |
| Dividend interest payment | 138.74%1.39M | 66.92%974.2K | 55.69%507.94K | 64.33%2.2M | -34.66%583.63K | -65.53%583.63K | --326.25K | 2,059.88%1.34M | 246.60%893.27K | 5,104.35%1.69M |
| Cash payments relating to other financing activities | -2.24%2.81M | -64.98%1.01M | -63.95%640.18K | -52.92%2.26M | 55.59%2.88M | --2.88M | --1.78M | -20.83%4.8M | 208.33%1.85M | ---- |
| Cash outflows from financing activities | -59.10%15.16M | -74.12%9.28M | 45.30%4.8M | 320.85%51.71M | 381.75%37.06M | 498.37%35.86M | -9.53%3.3M | 1.36%12.29M | -21.96%7.69M | -25.39%5.99M |
| Net cash flows from financing activities | -105.76%-15.16M | -103.65%-9.28M | -101.67%-4.8M | 2,120.76%248.29M | 4,509.43%262.94M | 4,340.39%254.14M | 7,954.73%286.7M | -101.85%-12.29M | -100.94%-5.96M | -97.63%-5.99M |
| Net cash flow | ||||||||||
| Exchange rate change effecting cash and cash equivalents | -100.02%-7.87 | -98.22%711.37 | -99.87%53.29 | -73.97%12.96K | 236.26%39.91K | -1.58%39.91K | --40.56K | 221.17%49.77K | 2.61%-29.29K | 234.63%40.55K |
| Net increase in cash and cash equivalents | 94.29%-15.16M | 64.45%-126.24M | 43.24%-46.92M | -142.09%-238.31M | -269.16%-265.69M | -215.36%-355.14M | 12.15%-82.67M | 303.54%566.15M | -49.15%157.06M | 217.69%307.84M |
| Add:Begin period cash and cash equivalents | -31.84%510.17M | -31.84%510.17M | -31.84%510.17M | 310.52%748.48M | 310.52%748.48M | 310.52%748.48M | 310.52%748.48M | -60.40%182.33M | -60.40%182.33M | -60.40%182.33M |
| End period cash equivalent | 2.53%495M | -2.39%383.92M | -30.42%463.24M | -31.84%510.17M | 42.26%482.79M | -19.75%393.34M | 654.71%665.81M | 310.52%748.48M | -55.89%339.38M | 146.44%490.16M |
| Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
| Accounting Standards | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) |
| Audit Opinions | -- | -- | -- | Unqualified opinion | -- | -- | -- | Unqualified opinion | -- | -- |
| Auditor | -- | -- | -- | China Audit Zhonghuan Certified Public Accountants Co., Ltd. (Special General Partnership) | -- | -- | -- | China Audit Zhonghuan Certified Public Accountants Co., Ltd. (Special General Partnership) | -- | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.
